AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE was reported 649 times

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SCHIZOTYPAL PERSONALITY DISORDER 1 0.0455
1 OROPHARYNGEAL NEOPLASM 1 0.0303
2 OTITIS EXTERNA FUNGAL 1 0.0294
3 IDIOPATHIC PANCREATITIS 1 0.0278
4 HYPERKERATOSIS PALMARIS AND PLANTARIS 1 0.0233
5 LARYNGITIS BACTERIAL 1 0.0189
6 CATHETER SITE SCAR 1 0.0167
7 LIVER PALPABLE 1 0.0141
8 DELAYED SLEEP PHASE 1 0.0122
9 CLONAL EVOLUTION 1 0.0096
10 DIVERTICULUM OESOPHAGEAL 1 0.0083
11 PERIPORTAL OEDEMA 1 0.0080
12 CAPSULE PHYSICAL ISSUE 1 0.0069
13 OCULAR ROSACEA 1 0.0049
14 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
15 PRODUCT ADVERTISING ISSUE 1 0.0047
16 MICROGRAPHIC SKIN SURGERY 1 0.0047
17 STOMA SITE DISCOMFORT 1 0.0044
18 GINGIVAL INJURY 1 0.0041
19 GASTRIC MUCOSAL HYPERTROPHY 1 0.0040
20 JUGULAR VEIN DISTENSION 2 0.0035
21 ADMINISTRATION SITE ERYTHEMA 1 0.0035
22 BURSA DISORDER 1 0.0034
23 ANKLE DEFORMITY 1 0.0031
24 GASTRIC MUCOSA ERYTHEMA 1 0.0030
25 ACQUIRED OESOPHAGEAL WEB 1 0.0029
26 SPINAL NERVE STIMULATOR IMPLANTATION 1 0.0029
27 COUNTERFEIT DRUG ADMINISTERED 1 0.0029
28 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
29 ADMINISTRATION SITE BRUISE 1 0.0029
30 ANION GAP DECREASED 1 0.0029
31 HYPERPARATHYROIDISM SECONDARY 7 0.0028
32 SCROTAL ABSCESS 1 0.0026
33 HAPTOGLOBIN DECREASED 2 0.0025
34 RETICULOCYTE COUNT INCREASED 2 0.0025
35 LYMPHOCYTE PERCENTAGE INCREASED 1 0.0025
36 DEGENERATIVE BONE DISEASE 1 0.0023
37 POST THROMBOTIC SYNDROME 1 0.0022
38 PERINEAL ABSCESS 1 0.0022
39 POST-TRAUMATIC PAIN 1 0.0022
40 PROTEIN URINE 2 0.0022
41 MEIBOMIAN GLAND DYSFUNCTION 1 0.0022
42 PULMONARY EOSINOPHILIA 1 0.0022
43 IMMUNOGLOBULINS INCREASED 1 0.0021
44 PIGMENTARY MACULOPATHY 1 0.0021
45 NEUTROPHIL PERCENTAGE DECREASED 1 0.0019
46 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
47 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 1 0.0018
48 COLON INJURY 1 0.0017
49 CARBON DIOXIDE DECREASED 2 0.0017
50 NEUROPSYCHOLOGICAL SYMPTOMS 1 0.0017
51 BLOOD VISCOSITY INCREASED 1 0.0017
52 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
53 BLADDER IRRITATION 1 0.0016
54 RUPTURED CEREBRAL ANEURYSM 1 0.0015
55 NEPHROGENIC ANAEMIA 7 0.0015
56 BRONCHITIS VIRAL 1 0.0015
57 KERATOACANTHOMA 1 0.0015
58 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0014
59 INJECTION SITE HYPOAESTHESIA 2 0.0014
60 PARATHYROID TUMOUR BENIGN 1 0.0013
61 AMINO ACID LEVEL INCREASED 1 0.0013
62 REBOUND ACID HYPERSECRETION 4 0.0013
63 ELECTROCARDIOGRAM PR PROLONGATION 1 0.0013
64 PARATHYROID DISORDER 1 0.0012
65 PENILE HAEMORRHAGE 1 0.0012
66 ANAEMIA HAEMOLYTIC AUTOIMMUNE 1 0.0012
67 MEAN CELL HAEMOGLOBIN INCREASED 2 0.0012
68 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
69 MEDICAL PROCEDURE 2 0.0012
70 MEAN PLATELET VOLUME DECREASED 1 0.0012
71 TYMPANIC MEMBRANE PERFORATION 2 0.0012
72 COLONIC ABSCESS 1 0.0012
73 ALLERGIC SINUSITIS 1 0.0012
74 FANCONI SYNDROME ACQUIRED 2 0.0011
75 BLOOD ALBUMIN INCREASED 1 0.0011
76 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
77 BLOOD MAGNESIUM INCREASED 1 0.0011
78 ADENOCARCINOMA GASTRIC 1 0.0011
79 INTENTIONAL MISUSE 2 0.0010
80 BLOOD URINE 1 0.0010
81 DRUG ADMINISTERED IN WRONG DEVICE 1 0.0010
82 BLADDER DYSFUNCTION 1 0.0010
83 WAIST CIRCUMFERENCE INCREASED 1 0.0010
84 PRODUCT BLISTER PACKAGING ISSUE 1 0.0010
85 PRODUCT COMMINGLING 1 0.0009
86 TOXIC ANTERIOR SEGMENT SYNDROME 1 0.0009
87 PROGRESSIVE MULTIPLE SCLEROSIS 1 0.0009
88 OPTIC NERVE INJURY 1 0.0009
89 INFUSION SITE WARMTH 1 0.0008
90 XEROSIS 1 0.0008
91 HYPERAESTHESIA TEETH 1 0.0008
92 BLOOD CHLORIDE DECREASED 2 0.0008
93 ANION GAP INCREASED 1 0.0007
94 CARBON DIOXIDE INCREASED 1 0.0007
95 ISCHAEMIC HEPATITIS 1 0.0007
96 MYELITIS TRANSVERSE 1 0.0007
97 FANCONI SYNDROME 1 0.0007
98 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
99 EYELID MARGIN CRUSTING 2 0.0007
100 STOMA SITE PAIN 1 0.0007
101 APRAXIA 1 0.0007
102 GINGIVAL HYPERTROPHY 1 0.0007
103 AGE-RELATED MACULAR DEGENERATION 1 0.0007
104 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
105 SPLEEN DISORDER 1 0.0006
106 LAZINESS 1 0.0006
107 VERTIGO POSITIONAL 1 0.0006
108 INFUSION SITE DISCHARGE 1 0.0006
109 DRUG SCREEN NEGATIVE 1 0.0006
110 FEAR OF DISEASE 1 0.0006
111 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
112 END STAGE RENAL DISEASE 10 0.0005
113 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
114 BLOOD IRON INCREASED 1 0.0005
115 PROTEIN TOTAL DECREASED 2 0.0005
116 GINGIVAL RECESSION 1 0.0005
117 HEPATIC MASS 1 0.0005
118 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
119 BLOOD PRESSURE INADEQUATELY CONTROLLED 3 0.0005
120 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
121 EYE CONTUSION 1 0.0005
122 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
123 MEDICAL DEVICE PAIN 1 0.0005
124 HYPERPHOSPHATAEMIA 1 0.0005
125 HORDEOLUM 2 0.0005
126 CHRONIC KIDNEY DISEASE 35 0.0005
127 PERICARDIAL HAEMORRHAGE 1 0.0005
128 CHRONIC GASTRITIS 1 0.0004
129 HAEMANGIOMA 1 0.0004
130 ANGIOEDEMA 19 0.0004
131 BILIRUBIN CONJUGATED INCREASED 1 0.0004
132 CONTRAST MEDIA REACTION 1 0.0004
133 SPINAL COLUMN STENOSIS 2 0.0004
134 LACUNAR INFARCTION 1 0.0004
135 DEVICE INFUSION ISSUE 1 0.0004
136 DIABETIC COMPLICATION 1 0.0004
137 ENDOCARDITIS 2 0.0004
138 MEAN CELL VOLUME INCREASED 1 0.0004
139 DRUG TITRATION ERROR 1 0.0004
140 COMPARTMENT SYNDROME 1 0.0004
141 BLOOD ALBUMIN DECREASED 3 0.0004
142 ABDOMINAL MASS 1 0.0004
143 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
144 PRODUCT SIZE ISSUE 2 0.0004
145 CHONDROPATHY 1 0.0004
146 MIGRAINE WITH AURA 1 0.0004
147 ASTHENOPIA 2 0.0004
148 CHOKING SENSATION 2 0.0004
149 MUSCLE INJURY 3 0.0004
150 CHOLECYSTITIS INFECTIVE 1 0.0004
151 COMPLETED SUICIDE 30 0.0004
152 OESOPHAGEAL STENOSIS 1 0.0004
153 DERMATITIS CONTACT 4 0.0004
154 TUMOUR HAEMORRHAGE 1 0.0004
155 INTERNAL HAEMORRHAGE 4 0.0003
156 MUSCLE STRAIN 3 0.0003
157 DYSPNOEA AT REST 1 0.0003
158 ADENOVIRUS INFECTION 1 0.0003
159 RALES 2 0.0003
160 DEVICE POWER SOURCE ISSUE 1 0.0003
161 METABOLIC ENCEPHALOPATHY 1 0.0003
162 EYE INJURY 1 0.0003
163 NEPHROPATHY 3 0.0003
164 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
165 BLOOD BLISTER 1 0.0003
166 BLOOD CREATININE DECREASED 1 0.0003
167 FOREIGN BODY IN THROAT 1 0.0003
168 INFUSION SITE PRURITUS 1 0.0003
169 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
170 RENAL TUBULAR NECROSIS 3 0.0003
171 INFUSION SITE HAEMORRHAGE 1 0.0003
172 PLANTAR FASCIITIS 1 0.0003
173 PRODUCT ODOUR ABNORMAL 3 0.0003
174 THROMBOTIC THROMBOCYTOPENIC PURPURA 1 0.0003
175 NECROTISING FASCIITIS 1 0.0003
176 DEPRESSIVE SYMPTOM 1 0.0003
177 MONOCYTE COUNT INCREASED 1 0.0003
178 FEELING DRUNK 2 0.0003
179 BLOOD CALCIUM DECREASED 3 0.0003
180 CHRONIC SINUSITIS 1 0.0003
181 CATHETER SITE INFECTION 1 0.0003
182 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
183 REHABILITATION THERAPY 1 0.0003
184 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
185 HAEMATOCRIT DECREASED 5 0.0003
186 INTRACRANIAL ANEURYSM 1 0.0002
187 RENAL FAILURE 33 0.0002
188 FUNGAL SKIN INFECTION 1 0.0002
189 SPINAL FUSION SURGERY 1 0.0002
190 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
191 EUGLYCAEMIC DIABETIC KETOACIDOSIS 1 0.0002
192 INFUSION SITE ERYTHEMA 2 0.0002
193 RENAL INJURY 7 0.0002
194 POOR PERIPHERAL CIRCULATION 1 0.0002
195 CARDIAC FAILURE CHRONIC 1 0.0002
196 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
197 INFUSION SITE PAIN 3 0.0002
198 BLOOD MAGNESIUM DECREASED 2 0.0002
199 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
200 URINE OUTPUT DECREASED 2 0.0002
201 DIVERTICULUM INTESTINAL 1 0.0002
202 INTENTIONAL DEVICE MISUSE 1 0.0002
203 PRODUCT SUBSTITUTION ISSUE 13 0.0002
204 DISEASE COMPLICATION 1 0.0002
205 EAR DISORDER 1 0.0002
206 INCREASED TENDENCY TO BRUISE 2 0.0002
207 NERVE COMPRESSION 2 0.0002
208 ARTHRITIS INFECTIVE 1 0.0002
209 YELLOW SKIN 1 0.0002
210 LACERATION 2 0.0002
211 DYSPNOEA EXERTIONAL 8 0.0002
212 BLOOD SODIUM DECREASED 4 0.0002
213 SEASONAL ALLERGY 3 0.0002
214 CARDIAC TAMPONADE 1 0.0002
215 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
216 VITAMIN D DEFICIENCY 2 0.0002
217 HORMONE LEVEL ABNORMAL 1 0.0002
218 PANCREATIC DISORDER 1 0.0002
219 STAPHYLOCOCCAL SEPSIS 1 0.0002
220 HYPERVOLAEMIA 1 0.0002
221 MULTIPLE DRUG OVERDOSE 1 0.0002
222 BLOOD PRESSURE ABNORMAL 4 0.0002
223 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
224 ECONOMIC PROBLEM 3 0.0002
225 PATHOLOGICAL FRACTURE 1 0.0002
226 MOTOR DYSFUNCTION 2 0.0002
227 AMMONIA INCREASED 1 0.0002
228 PRODUCT COLOUR ISSUE 1 0.0002
229 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
230 UNRESPONSIVE TO STIMULI 5 0.0002
231 PARTIAL SEIZURES 1 0.0002
232 CATATONIA 1 0.0002
233 ANHEDONIA 5 0.0002
234 SCRATCH 2 0.0002
235 SERUM FERRITIN INCREASED 1 0.0002
236 NYSTAGMUS 1 0.0002
237 ANORECTAL DISCOMFORT 1 0.0002
238 FOOD POISONING 1 0.0002
239 HEREDITARY ANGIOEDEMA 2 0.0002
240 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
241 ANAL ABSCESS 1 0.0002
242 BRUXISM 1 0.0002
243 BLOOD BILIRUBIN INCREASED 5 0.0002
244 CHEILITIS 1 0.0002
245 BLOOD POTASSIUM INCREASED 3 0.0002
246 PULMONARY THROMBOSIS 2 0.0002
247 WOUND INFECTION 2 0.0002
248 JAW DISORDER 1 0.0002
249 GASTROINTESTINAL PAIN 2 0.0002
250 ACUTE PULMONARY OEDEMA 1 0.0002
251 PERONEAL NERVE PALSY 1 0.0002
252 RED BLOOD CELL COUNT DECREASED 5 0.0002
253 MOUTH SWELLING 1 0.0002
254 ACUTE KIDNEY INJURY 26 0.0002
255 HEAD DISCOMFORT 3 0.0002
256 ENERGY INCREASED 1 0.0002
257 ODYNOPHAGIA 1 0.0002
258 GOUT 3 0.0002
259 SYMPTOM RECURRENCE 1 0.0002
260 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
261 DERMATITIS ACNEIFORM 1 0.0002
262 PIGMENTATION DISORDER 1 0.0002
263 NASAL DRYNESS 1 0.0002
264 BRAIN OEDEMA 2 0.0002
265 BLOOD URINE PRESENT 3 0.0002
266 FOREIGN BODY SENSATION IN EYES 1 0.0002
267 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
268 CARDIAC FLUTTER 1 0.0002
269 HIATUS HERNIA 2 0.0002
270 APPLICATION SITE VESICLES 1 0.0002
271 PRODUCT PREPARATION ISSUE 1 0.0002
272 PRODUCT FORMULATION ISSUE 1 0.0002
273 CORONAVIRUS INFECTION 1 0.0002
274 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
275 LIP SWELLING 5 0.0001
276 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
277 PRODUCT TASTE ABNORMAL 2 0.0001
278 LIMB INJURY 4 0.0001
279 IMPAIRED GASTRIC EMPTYING 2 0.0001
280 NEPHROTIC SYNDROME 1 0.0001
281 HAIR GROWTH ABNORMAL 1 0.0001
282 POLLAKIURIA 6 0.0001
283 DEFAECATION URGENCY 1 0.0001
284 DUODENAL ULCER 1 0.0001
285 DIVERTICULUM 1 0.0001
286 RETCHING 3 0.0001
287 RETINAL HAEMORRHAGE 1 0.0001
288 METASTASIS 1 0.0001
289 HYPOPHOSPHATAEMIA 1 0.0001
290 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
291 PULMONARY MASS 2 0.0001
292 HYDRONEPHROSIS 1 0.0001
293 PAROSMIA 1 0.0001
294 CORONARY ARTERY DISEASE 4 0.0001
295 TENDON PAIN 1 0.0001
296 PRODUCT AVAILABILITY ISSUE 3 0.0001
297 INSURANCE ISSUE 2 0.0001
298 LIPASE INCREASED 1 0.0001
299 MUSCLE TWITCHING 3 0.0001
300 RENAL FAILURE CHRONIC 1 0.0001
301 EJECTION FRACTION DECREASED 2 0.0001
302 HAEMORRHAGIC STROKE 1 0.0001
303 GASTROINTESTINAL INFLAMMATION 1 0.0001
304 MULTIPLE ALLERGIES 1 0.0001
305 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
306 PNEUMOTHORAX 2 0.0001
307 RESPIRATORY TRACT CONGESTION 2 0.0001
308 ULCER 2 0.0001
309 GINGIVAL PAIN 1 0.0001
310 UTERINE CANCER 1 0.0001
311 FRUSTRATION TOLERANCE DECREASED 1 0.0001
312 ABNORMAL FAECES 1 0.0001
313 HYPERAESTHESIA 1 0.0001
314 HAIR DISORDER 1 0.0001
315 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1 0.0001
316 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
317 EOSINOPHIL COUNT INCREASED 1 0.0001
318 HOT FLUSH 9 0.0001
319 SENSATION OF FOREIGN BODY 1 0.0001
320 BLOOD PRESSURE INCREASED 18 0.0001
321 VITAMIN D DECREASED 1 0.0001
322 SCAR 2 0.0001
323 MUSCULOSKELETAL DISCOMFORT 2 0.0001
324 ANURIA 1 0.0001
325 SKIN ULCER 3 0.0001
326 PSYCHOLOGICAL TRAUMA 1 0.0001
327 BLOOD CALCIUM INCREASED 1 0.0001
328 HYPOXIA 4 0.0001
329 PANCREATITIS 6 0.0001
330 LYMPHOCYTE COUNT DECREASED 2 0.0001
331 GALLBLADDER DISORDER 2 0.0001
332 THROMBOSIS 9 0.0001
333 ANAL INCONTINENCE 1 0.0001
334 TOOTHACHE 2 0.0001
335 OSTEOMYELITIS 2 0.0001
336 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
337 PAIN IN JAW 3 0.0001
338 BLOOD PRESSURE DECREASED 7 0.0001
339 DEHYDRATION 14 0.0001
340 INCREASED APPETITE 2 0.0001
341 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
342 DIZZINESS POSTURAL 1 0.0001
343 HAEMORRHOIDS 2 0.0001
344 COELIAC DISEASE 1 0.0001
345 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
346 LABORATORY TEST ABNORMAL 3 0.0001
347 PRESCRIBED UNDERDOSE 2 0.0001
348 BLOOD POTASSIUM DECREASED 3 0.0001
349 EMPHYSEMA 1 0.0001
350 DRY THROAT 1 0.0001
351 NEUTROPHIL COUNT INCREASED 1 0.0001
352 EUPHORIC MOOD 1 0.0001
353 EAR DISCOMFORT 1 0.0001
354 INJECTION SITE WARMTH 2 0.0001
355 EYE DISCHARGE 1 0.0001
356 PULMONARY HYPERTENSION 2 0.0001
357 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
358 ABDOMINAL DISTENSION 10 0.0001
359 WEIGHT FLUCTUATION 1 0.0001
360 WITHDRAWAL SYNDROME 4 0.0001
361 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
362 FULL BLOOD COUNT ABNORMAL 1 0.0001
363 SUDDEN DEATH 1 0.0001
364 RENAL PAIN 1 0.0001
365 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
366 DYSGEUSIA 7 0.0001
367 BREAST PAIN 1 0.0001
368 JOINT INJURY 2 0.0001
369 MOVEMENT DISORDER 3 0.0001
370 IRRITABLE BOWEL SYNDROME 2 0.0001
371 HYPOACUSIS 4 0.0001
372 DECREASED ACTIVITY 1 0.0001
373 BIPOLAR DISORDER 1 0.0001
374 EYE DISORDER 3 0.0001
375 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
376 DENTAL CARIES 1 0.0001
377 TRANSAMINASES INCREASED 2 0.0001
378 NERVE INJURY 1 0.0001
379 HYPERTENSIVE CRISIS 1 0.0001
380 SNEEZING 2 0.0001
381 SKIN INFECTION 1 0.0001
382 FISTULA 1 0.0001
383 EYE INFECTION 1 0.0001
384 SCAB 1 0.0001
385 MYOCARDITIS 1 0.0001
386 TINNITUS 4 0.0001
387 NEOPLASM 1 0.0001
388 MADAROSIS 1 0.0001
389 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
390 COVID-19 PNEUMONIA 1 0.0001
391 BACTERAEMIA 1 0.0001
392 ATAXIA 1 0.0001
393 MACULAR DEGENERATION 1 0.0001
394 MULTIPLE SCLEROSIS 4 0.0001
395 WRIST FRACTURE 1 0.0001
396 BLOOD PRESSURE FLUCTUATION 2 0.0001
397 STOMATITIS 5 0.0001
398 BURSITIS 1 0.0001
399 NOCTURIA 1 0.0001
400 SCHIZOPHRENIA 1 0.0001
401 PLEURAL EFFUSION 5 0.0001
402 NO THERAPEUTIC RESPONSE 1 0.0001
403 MUSCLE SPASMS 15 0.0001
404 CARDIOMEGALY 1 0.0001
405 SMALL INTESTINAL OBSTRUCTION 1 0.0001
406 BRONCHITIS 6 0.0001
407 BALANCE DISORDER 7 0.0001
408 EYE SWELLING 3 0.0001
409 PHARYNGITIS 1 0.0001
410 HAIR COLOUR CHANGES 1 0.0001
411 AGEUSIA 2 0.0001
412 DRY EYE 4 0.0001
413 PNEUMONIA ASPIRATION 2 0.0001
414 POISONING 1 0.0001
415 MUSCLE ATROPHY 1 0.0001
416 HAEMATEMESIS 2 0.0001
417 INJECTION SITE IRRITATION 1 0.0001
418 HYPOPHAGIA 2 0.0001
419 LOSS OF CONSCIOUSNESS 10 0.0001
420 THERAPY CESSATION 4 0.0001
421 ERECTILE DYSFUNCTION 2 0.0001
422 ANXIETY 22 0.0001
423 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
424 PLASMA CELL MYELOMA 3 0.0001
425 IMMUNE SYSTEM DISORDER 1 0.0001
426 PULMONARY CONGESTION 1 0.0001
427 ADVERSE REACTION 1 0.0001
428 WEIGHT DECREASED 21 0.0001
429 EYE HAEMORRHAGE 1 0.0001
430 HAIR TEXTURE ABNORMAL 1 0.0001
431 JOINT RANGE OF MOTION DECREASED 1 0.0001
432 QUALITY OF LIFE DECREASED 1 0.0001
433 SINUS CONGESTION 1 0.0001
434 DRY MOUTH 6 0.0001
435 TREATMENT NONCOMPLIANCE 4 0.0001
436 SKIN LESION 2 0.0001
437 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
438 MENTAL STATUS CHANGES 2 0.0001
439 HYPOMAGNESAEMIA 1 0.0001
440 COORDINATION ABNORMAL 1 0.0001
441 WOUND 2 0.0001
442 OXYGEN SATURATION DECREASED 4 0.0001
443 BLOOD TEST ABNORMAL 1 0.0001
444 DYSPEPSIA 7 0.0001
445 BLINDNESS UNILATERAL 1 0.0001
446 DIALYSIS 1 0.0001
447 INTENTIONAL DOSE OMISSION 2 0.0001
448 BRONCHOSPASM 1 0.0001
449 IMPAIRED QUALITY OF LIFE 1 0.0001
450 PARAESTHESIA ORAL 1 0.0001
451 ASTHENIA 26 0.0001
452 SURGERY 4 0.0001
453 HAEMOGLOBIN DECREASED 7 0.0001
454 DIARRHOEA 44 0.0001
455 COUGH 19 0.0001
456 DISEASE PROGRESSION 8 0.0001
457 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
458 SKIN HAEMORRHAGE 1 0.0001
459 RESPIRATORY DISORDER 2 0.0001
460 LACRIMATION INCREASED 2 0.0001
461 HYPERTENSION 14 0.0001
462 DEVICE FAILURE 1 0.0001
463 ABDOMINAL DISCOMFORT 11 0.0001
464 HIP ARTHROPLASTY 1 0.0001
465 SKIN DISCOLOURATION 3 0.0001
466 DEVICE ADHESION ISSUE 1 0.0001
467 DEVICE RELATED INFECTION 1 0.0001
468 PERIPHERAL SWELLING 10 0.0001
469 MYALGIA 11 0.0001
470 LIMB DISCOMFORT 2 0.0001
471 TENDONITIS 1 0.0001
472 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
473 URINARY TRACT INFECTION 11 0.0001
474 CONSTIPATION 14 0.0001
475 SWOLLEN TONGUE 2 0.0001
476 BRAIN FOG 1 0.0001
477 PRODUCT USE COMPLAINT 1 0.0001
478 HEAD INJURY 2 0.0001
479 HALLUCINATION, AUDITORY 1 0.0001
480 CYSTITIS 2 0.0001
481 INFLUENZA 7 0.0001
482 CONTUSION 6 0.0001
483 CARDIAC FAILURE CONGESTIVE 5 0.0001
484 HIP FRACTURE 2 0.0001
485 SWELLING FACE 4 0.0001
486 PAIN IN EXTREMITY 18 0.0001
487 METASTASES TO BONE 1 0.0001
488 INFLUENZA LIKE ILLNESS 5 0.0001
489 HEART RATE INCREASED 6 0.0001
490 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
491 GAIT INABILITY 2 0.0001
492 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
493 BLOOD UREA INCREASED 1 0.0001
494 VOMITING 28 0.0001
495 CELLULITIS 3 0.0001
496 EYE PRURITUS 2 0.0001
497 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
498 HYPERSENSITIVITY 11 0.0001
499 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
500 FATIGUE 46 0.0001
501 HEMIPARESIS 1 0.0001
502 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
503 CIRCULATORY COLLAPSE 1 0.0001
504 HEPATIC ENZYME INCREASED 4 0.0001
505 ILLNESS 6 0.0001
506 OEDEMA PERIPHERAL 7 0.0001
507 ORTHOSTATIC HYPOTENSION 1 0.0001
508 NERVOUSNESS 3 0.0001
509 MUSCULOSKELETAL STIFFNESS 5 0.0001
510 HYPERKALAEMIA 2 0.0001
511 COVID-19 10 0.0001
512 HEART RATE DECREASED 2 0.0001
513 INJURY 4 0.0001
514 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
515 LYMPHADENOPATHY 2 0.0001
516 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
517 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
518 DRUG ERUPTION 1 0.0001
519 MOBILITY DECREASED 4 0.0001
520 PNEUMONIA 18 0.0001
521 GASTROENTERITIS VIRAL 1 0.0001
522 RESPIRATORY FAILURE 4 0.0001
523 DYSURIA 2 0.0001
524 ANAPHYLACTIC REACTION 3 0.0001
525 NASOPHARYNGITIS 10 0.0001
526 INJECTION SITE MASS 2 0.0001
527 SEPSIS 6 0.0001
528 BACTERIAL INFECTION 1 0.0001
529 MIDDLE INSOMNIA 1 0.0001
530 EPISTAXIS 4 0.0001
531 PRODUCT USE ISSUE 10 0.0001
532 DYSPNOEA 30 0.0001
533 HYPOCALCAEMIA 1 0.0001
534 DYSPHAGIA 5 0.0001
535 GASTRIC ULCER 1 0.0001
536 PROTEINURIA 1 0.0001
537 INSOMNIA 14 0.0001
538 MUSCULOSKELETAL DISORDER 1 0.0001
539 DIABETES MELLITUS 4 0.0001
540 SLEEP APNOEA SYNDROME 1 0.0001
541 LETHARGY 3 0.0001
542 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
543 LOWER LIMB FRACTURE 1 0.0001
544 DRUG PRESCRIBING ERROR 1 0.0001
545 ACUTE RESPIRATORY FAILURE 1 0.0001
546 GLAUCOMA 1 0.0001
547 PRODUCT QUALITY ISSUE 7 0.0001
548 ATRIAL FIBRILLATION 5 0.0001
549 DYSPHONIA 3 0.0001
550 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
551 CHOKING 1 0.0001
552 PRODUCT DOSE OMISSION ISSUE 15 0.0001
553 ALOPECIA 10 0.0001
554 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
555 SINUS DISORDER 1 0.0001
556 DISORIENTATION 2 0.0001
557 UPPER LIMB FRACTURE 1 0.0001
558 FEELING ABNORMAL 12 0.0001
559 SPINAL FRACTURE 1 0.0000
560 IRRITABILITY 3 0.0000
561 JOINT SWELLING 6 0.0000
562 FULL BLOOD COUNT DECREASED 1 0.0000
563 EMOTIONAL DISTRESS 6 0.0000
564 EXTRA DOSE ADMINISTERED 2 0.0000
565 TASTE DISORDER 1 0.0000
566 PSORIATIC ARTHROPATHY 2 0.0000
567 DYSKINESIA 2 0.0000
568 DISCOMFORT 3 0.0000
569 INJURY ASSOCIATED WITH DEVICE 1 0.0000
570 CHEST DISCOMFORT 5 0.0000
571 PRODUCT PREPARATION ERROR 1 0.0000
572 OSTEOPOROSIS 2 0.0000
573 CHEST PAIN 9 0.0000
574 VISUAL IMPAIRMENT 6 0.0000
575 FALL 16 0.0000
576 HEADACHE 30 0.0000
577 INTENTIONAL DRUG MISUSE 1 0.0000
578 CARDIO-RESPIRATORY ARREST 2 0.0000
579 DERMATITIS 1 0.0000
580 KNEE ARTHROPLASTY 1 0.0000
581 SKIN EXFOLIATION 4 0.0000
582 HALLUCINATION, VISUAL 1 0.0000
583 PLATELET COUNT DECREASED 5 0.0000
584 PRURITUS 18 0.0000
585 IMPAIRED WORK ABILITY 1 0.0000
586 HYPOAESTHESIA 7 0.0000
587 NAUSEA 37 0.0000
588 LIVER FUNCTION TEST INCREASED 1 0.0000
589 RHINORRHOEA 3 0.0000
590 DEEP VEIN THROMBOSIS 3 0.0000
591 FAECES DISCOLOURED 1 0.0000
592 BLOOD CREATININE INCREASED 3 0.0000
593 ARTHRALGIA 19 0.0000
594 RASH MACULO-PAPULAR 1 0.0000
595 PULMONARY OEDEMA 2 0.0000
596 ORAL PAIN 1 0.0000
597 THROAT IRRITATION 2 0.0000
598 ASTHMA 5 0.0000
599 DEPRESSION 10 0.0000
600 INJECTION SITE REACTION 3 0.0000
601 HYPOKALAEMIA 2 0.0000
602 CONFUSIONAL STATE 7 0.0000
603 BACK PAIN 10 0.0000
604 PALPITATIONS 5 0.0000
605 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
606 RENAL CANCER 2 0.0000
607 THERAPY INTERRUPTED 3 0.0000
608 PRODUCTIVE COUGH 2 0.0000
609 INFECTION 6 0.0000
610 DRUG INTOLERANCE 4 0.0000
611 LUNG DISORDER 2 0.0000
612 ABASIA 1 0.0000
613 OSTEONECROSIS OF JAW 1 0.0000
614 SYNCOPE 4 0.0000
615 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
616 HOSPITALISATION 6 0.0000
617 SINUSITIS 4 0.0000
618 ERYTHEMA 8 0.0000
619 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
620 ABDOMINAL PAIN UPPER 8 0.0000
621 ANAPHYLACTIC SHOCK 1 0.0000
622 DECREASED APPETITE 9 0.0000
623 HAEMATOMA 1 0.0000
624 EXPOSURE VIA SKIN CONTACT 1 0.0000
625 RESPIRATORY TRACT INFECTION 1 0.0000
626 DEAFNESS 1 0.0000
627 SEDATION 1 0.0000
628 MUSCULOSKELETAL PAIN 2 0.0000
629 DIZZINESS 19 0.0000
630 GASTRITIS 1 0.0000
631 DRY SKIN 5 0.0000
632 PAIN 23 0.0000
633 FEAR 1 0.0000
634 JAUNDICE 1 0.0000
635 DISTURBANCE IN ATTENTION 2 0.0000
636 THROAT TIGHTNESS 1 0.0000
637 MOOD ALTERED 1 0.0000
638 GAIT DISTURBANCE 7 0.0000
639 MEMORY IMPAIRMENT 5 0.0000
640 CARDIAC ARREST 3 0.0000
641 DRUG DOSE OMISSION 6 0.0000
642 RESPIRATORY ARREST 1 0.0000
643 HAEMATOCHEZIA 2 0.0000
644 RESPIRATORY DISTRESS 1 0.0000
645 TREMOR 6 0.0000
646 DIVERTICULITIS 1 0.0000
647 MEDICATION ERROR 2 0.0000
648 PANCYTOPENIA 2 0.0000
649 DEMENTIA 1 0.0000
650 BLISTER 2 0.0000
651 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
652 HERPES ZOSTER 2 0.0000
653 EYE IRRITATION 2 0.0000
654 MALAISE 15 0.0000
655 CHILLS 4 0.0000
656 ASCITES 1 0.0000
657 ACUTE MYOCARDIAL INFARCTION 1 0.0000
658 URINARY INCONTINENCE 1 0.0000
659 CATARACT 2 0.0000
660 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
661 HEPATIC FAILURE 1 0.0000
662 ILL-DEFINED DISORDER 2 0.0000
663 VERTIGO 2 0.0000
664 INJECTION SITE PAIN 10 0.0000
665 INJECTION SITE RASH 1 0.0000
666 FEMUR FRACTURE 1 0.0000
667 SWELLING 3 0.0000
668 BONE DENSITY DECREASED 1 0.0000
669 DRUG-INDUCED LIVER INJURY 1 0.0000
670 DRUG INEFFECTIVE 42 0.0000
671 PARAESTHESIA 5 0.0000
672 METABOLIC ACIDOSIS 1 0.0000
673 WEIGHT INCREASED 7 0.0000
674 INTENTIONAL OVERDOSE 2 0.0000
675 LACTIC ACIDOSIS 1 0.0000
676 PRODUCT DOSE OMISSION 2 0.0000
677 STAPHYLOCOCCAL INFECTION 1 0.0000
678 VISUAL ACUITY REDUCED 1 0.0000
679 FUNGAL INFECTION 1 0.0000
680 SKIN DISORDER 1 0.0000
681 HYPOTENSION 6 0.0000
682 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
683 GASTRIC DISORDER 1 0.0000
684 NIGHTMARE 1 0.0000
685 DELIRIUM 1 0.0000
686 NEOPLASM PROGRESSION 1 0.0000
687 RASH MACULAR 1 0.0000
688 BURNING SENSATION 2 0.0000
689 DEVICE MALFUNCTION 2 0.0000
690 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
691 PRODUCT ADHESION ISSUE 1 0.0000
692 CEREBRAL HAEMORRHAGE 1 0.0000
693 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
694 HYPERGLYCAEMIA 1 0.0000
695 PANIC ATTACK 1 0.0000
696 ACCIDENTAL OVERDOSE 1 0.0000
697 RESTLESSNESS 1 0.0000
698 DEATH 23 0.0000
699 BLOOD GLUCOSE INCREASED 5 0.0000
700 ANAEMIA 5 0.0000
701 INJECTION SITE SWELLING 2 0.0000
702 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
703 ARTHRITIS 2 0.0000
704 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
705 CARDIAC FAILURE 2 0.0000
706 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
707 DEVICE BREAKAGE 1 0.0000
708 BLINDNESS 1 0.0000
709 NEUTROPHIL COUNT DECREASED 1 0.0000
710 LUNG NEOPLASM MALIGNANT 1 0.0000
711 TREATMENT FAILURE 2 0.0000
712 OFF LABEL USE 21 0.0000
713 RHABDOMYOLYSIS 1 0.0000
714 ROAD TRAFFIC ACCIDENT 1 0.0000
715 URTICARIA 4 0.0000
716 OSTEOARTHRITIS 1 0.0000
717 DEVICE LEAKAGE 1 0.0000
718 DEVICE DISLOCATION 1 0.0000
719 SEPTIC SHOCK 1 0.0000
720 MENTAL DISORDER 1 0.0000
721 PSORIASIS 3 0.0000
722 RASH 10 0.0000
723 INTENTIONAL PRODUCT MISUSE 2 0.0000
724 LIVER DISORDER 1 0.0000
725 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
726 GASTROINTESTINAL DISORDER 2 0.0000
727 DEVICE ISSUE 2 0.0000
728 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
729 THERAPY NON-RESPONDER 1 0.0000
730 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
731 VISION BLURRED 3 0.0000
732 SKIN IRRITATION 1 0.0000
733 OROPHARYNGEAL PAIN 2 0.0000
734 BREAST CANCER 2 0.0000
735 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
736 CARDIAC DISORDER 2 0.0000
737 ARRHYTHMIA 1 0.0000
738 OCULAR HYPERAEMIA 1 0.0000
739 PULMONARY EMBOLISM 2 0.0000
740 NEUROPATHY PERIPHERAL 2 0.0000
741 DISEASE RECURRENCE 1 0.0000
742 RASH ERYTHEMATOUS 1 0.0000
743 BLOOD GLUCOSE DECREASED 1 0.0000
744 INTERSTITIAL LUNG DISEASE 1 0.0000
745 LEUKOPENIA 1 0.0000
746 SOMNOLENCE 4 0.0000
747 FLUSHING 2 0.0000
748 FLUID RETENTION 1 0.0000
749 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
750 HAEMORRHAGE 2 0.0000
751 ECZEMA 1 0.0000
752 SPEECH DISORDER 1 0.0000
753 DERMATITIS ATOPIC 1 0.0000
754 DEPRESSED MOOD 1 0.0000
755 RASH PRURITIC 1 0.0000
756 ARTHROPATHY 1 0.0000
757 NECK PAIN 1 0.0000
758 THROMBOCYTOPENIA 2 0.0000
759 TOXICITY TO VARIOUS AGENTS 3 0.0000
760 HYPONATRAEMIA 1 0.0000
761 FLATULENCE 1 0.0000
762 MUSCULAR WEAKNESS 2 0.0000
763 INCORRECT DOSE ADMINISTERED 4 0.0000
764 CONVULSION 1 0.0000
765 MYOCARDIAL INFARCTION 3 0.0000
766 ABDOMINAL PAIN 4 0.0000
767 BONE PAIN 1 0.0000
768 BLADDER CANCER 1 0.0000
769 WHEEZING 1 0.0000
770 THERAPEUTIC RESPONSE DECREASED 1 0.0000
771 FEELING HOT 1 0.0000
772 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
773 INJECTION SITE ERYTHEMA 2 0.0000
774 EXPOSURE DURING PREGNANCY 1 0.0000
775 HYPERHIDROSIS 2 0.0000
776 AMNESIA 1 0.0000
777 DEVICE DIFFICULT TO USE 1 0.0000
778 INFUSION RELATED REACTION 1 0.0000
779 NEOPLASM MALIGNANT 1 0.0000
780 INJECTION SITE PRURITUS 1 0.0000
781 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
782 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
783 SKIN BURNING SENSATION 1 0.0000
784 HALLUCINATION 1 0.0000
785 UNEVALUABLE EVENT 1 0.0000
786 ACNE 1 0.0000
787 INJECTION SITE HAEMORRHAGE 1 0.0000
788 PROSTATE CANCER 1 0.0000
789 RENAL IMPAIRMENT 1 0.0000
790 DRUG WITHDRAWAL SYNDROME 1 0.0000
791 TACHYCARDIA 1 0.0000
792 ADVERSE DRUG REACTION 1 0.0000
793 NO ADVERSE EVENT 2 0.0000
794 SUICIDAL IDEATION 1 0.0000
795 ADVERSE EVENT 1 0.0000
796 MIGRAINE 1 0.0000
797 CONDITION AGGRAVATED 3 0.0000
798 OVERDOSE 2 0.0000
799 RHEUMATOID ARTHRITIS 1 0.0000
800 PYREXIA 3 0.0000
801 NEUTROPENIA 1 0.0000
802 CEREBROVASCULAR ACCIDENT 1 0.0000